12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga·03/16/2026 21:05:49
Listen to the news
Gainers
- iSpecimen (NASDAQ:ISPC) shares rose 21.1% to $0.24 during Monday's after-market session. The company's market cap stands at $2.7 million.
- Cue Biopharma (NASDAQ:CUE) shares increased by 19.71% to $0.37. The company's market cap stands at $25.8 million. As per the press release, Q4 earnings came out today.
- Akari Therapeutics (NASDAQ:AKTX) stock moved upwards by 16.42% to $0.24. The market value of their outstanding shares is at $8.1 million.
- DocGo (NASDAQ:DCGO) shares increased by 12.74% to $0.73. The market value of their outstanding shares is at $64.2 million. As per the news, the Q4 earnings report came out today.
- WORK Medical Tech Gr (NASDAQ:WOK) shares moved upwards by 6.72% to $1.27.
- Assertio Holdings (NASDAQ:ASRT) stock rose 6.1% to $12.49. The company's market cap stands at $74.0 million. The company's, Q4 earnings came out today.
Losers
- LENSAR (NASDAQ:LNSR) stock decreased by 22.4% to $7.96 during Monday's after-market session. The market value of their outstanding shares is at $117.5 million.
- Nasus Pharma (AMEX:NSRX) shares decreased by 8.39% to $2.84. The company's market cap stands at $58.5 million.
- Inspira Technologies Oxy (NASDAQ:IINN) stock decreased by 7.77% to $0.55. The market value of their outstanding shares is at $24.1 million.
- Lunai Bioworks (NASDAQ:LNAI) stock declined by 7.41% to $0.2. The market value of their outstanding shares is at $4.4 million.
- Azitra (AMEX:AZTR) stock fell 6.49% to $0.15. The company's market cap stands at $1.8 million.
- Skye Bioscience (NASDAQ:SKYE) shares declined by 6.39% to $0.67. The market value of their outstanding shares is at $21.1 million. The company's, Q4 earnings came out 4 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.